Opioid Practice Group

Chronic pain has been a public health concern for decades. In managing this condition, healthcare providers have relied on opioids and other medications. With the increase in prescription opioids, healthcare providers have found themselves at the center of an opioid epidemic. Deaths from opioid overdose have increased by 200% since 2000, and opioid overdose now surpasses automobile accidents as the leading cause of accidental death in the United States. The Center for Disease Control and Prevention classifies addiction to opioids as an epidemic. Regulatory agencies and plaintiff attorneys have dramatically increased filings and suits against healthcare providers over opioid prescription, dispensing and administration. In this environment, healthcare providers require attorneys experienced with the legal challenges this opioid crisis has created. The HPS Opioid Practice Group is ready to help healthcare providers affected by the opioid crisis.

As the response to America’s opioid epidemic continues to evolve, so do the complex issues surrounding the regulation and use of opioids and other drugs in the healthcare market. Numerous jurisdictions have added or amended statutes and reporting requirements. In addition to the Comprehensive Addiction Recovery Act (“CARA”), the CDC Guidelines for Prescribing Opioids and the Federation of State Medical Boards Guidelines adopted by 12 states, various medical groups, including the AMA and the AAPM, have issued recent statements for optimal application of these guidelines.

HPS created this Practice Group to assist healthcare providers with their practices in prescribing, dispensing administering and managing opioids. The HPS Opioid Practice Group advises providers regarding laws and regulations concerning the prescription of opioids, assists providers in developing best practices for opioid management and defends healthcare providers facing allegations relating to the prescription, dispensing and administration of these medications. This Practice Group is comprised of dedicated attorneys with decades of experience in the healthcare industry, both in the litigation and regulatory arenas. Our team is well-versed on the changing laws and regulations surrounding the opioid crisis. 

The HPS Opioid Practice Group is at the forefront of:

  • Consulting with healthcare providers who require assistance in solving legal, clinical, and business issues surrounding the opioid epidemic;
  • Educating healthcare providers on the use of new technologies and pain alternatives and their role as part of best practices;
  • Educating healthcare providers on complex compliance concerns surrounding new laws and regulations designed to address the opioid epidemic;
  • Advising healthcare providers regarding credentialing qualifications which affect Medicare and Medicaid reimbursement;
  • Defending clients against allegations of improper marketing, prescription, dispensing and administration of opioids;
  • Defending healthcare providers in licensing and regulatory actions; and
  • Defending hospitals and healthcare providers against allegations of negligent prescription, dispensing and administration of opioids and other scheduled drugs.